Jacob Lalezari

13.9k citations
141 papers · 6.9k · 2 hit papers · h-index 45

Impact in

  • Virology top 0.1%
    • HIV Research and Treatment
  • Hepatology top 0.5%
    • Hepatitis C virus research

Papers in

    • Cytomegalovirus and herpesvirus research 30
    • Herpesvirus Infections and Treatments 16
    • Hepatitis B Virus Studies 11
    • Liver Disease Diagnosis and Treatment 9
    • HIV/AIDS drug development and treatment 49
    • HIV/AIDS Research and Interventions 11

Jacob Lalezari

135 papers receiving 6.6k citations

Jacob Lalezari's Hit Papers

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection 2008 · 572 citations
5720+7+15Years since publication200400600

Peers

Jacob Lalezari
Comparison fields: 5 of 112
  • Virology 2.4k
  • Hepatology 1.2k
  • Infectious Diseases 2.9k
  • Epidemiology 3.1k
  • Ophthalmology 222
Replace Michael A. Polis with:
Michael A. Polis United States
Sophie Matheron France
Shinichi Oka Japan
Clyde S. Crumpacker United States
Alejo Erice United States
Richard C. Reichman United States
Shyam Kottilil United States
Harold A. Kessler United States
Hiroyuki Gatanaga Japan
Sunwen Chou United States
Jacob Lalezari relative to Michael A. Polis United States Michael A. Polis's profile →
Citations per field
00.5×1.5×
Michael A. Polis · 1×
Citations per year

Countries citing papers authored by Jacob Lalezari

Since Specialization
Citations

This map shows the geographic impact of Jacob Lalezari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Lalezari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Lalezari more than expected).

Fields of papers citing papers by Jacob Lalezari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Lalezari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Lalezari. The network helps show where Jacob Lalezari may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacob Lalezari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacob Lalezari Line = papers co-authored together Jacob Lalezari links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
Hit paper breakdown →
2003718
2
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
Hit paper breakdown →
2008572
3 2007403
4 1997271
5 1996222
6 1995197
7 2014189
8 1995153
9 2002152
10 2014148
11 2009147
12 1995143
13 1997136
14 2019120
15 2002119
16 1997114
17 2003113
18 2001108
19 2001100
20 201497

About Jacob Lalezari

Jacob Lalezari is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Virology and Rheumatology, having authored 141 papers that have together received 6.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (49 papers), Hepatitis C virus research (43 papers), HIV Research and Treatment (37 papers), Cytomegalovirus and herpesvirus research (30 papers), Herpesvirus Infections and Treatments (16 papers), Hepatitis B Virus Studies (11 papers), HIV/AIDS Research and Interventions (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). The work is most often cited by research in Virology (2.4k citations), Hepatology (1.2k citations), Infectious Diseases (2.9k citations), Epidemiology (3.1k citations) and Ophthalmology (222 citations). Jacob Lalezari has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include William Drew, Calvin Cohen, Edwin DeJesus, Joseph J. Eron, Stephen Follansbee, Howard S. Jaffe, Ralph DeMasi, Peter J. Piliero, John Delehanty and Miklos Salgo. Their work appears in journals such as Journal of Hepatology, The Journal of Infectious Diseases, Gastroenterology, Antimicrobial Agents and Chemotherapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact